CN107613973A - 化学合成吡咯连接的二价化合物的方法及其组合物 - Google Patents

化学合成吡咯连接的二价化合物的方法及其组合物 Download PDF

Info

Publication number
CN107613973A
CN107613973A CN201680016569.4A CN201680016569A CN107613973A CN 107613973 A CN107613973 A CN 107613973A CN 201680016569 A CN201680016569 A CN 201680016569A CN 107613973 A CN107613973 A CN 107613973A
Authority
CN
China
Prior art keywords
compound
reaction
formula
salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680016569.4A
Other languages
English (en)
Chinese (zh)
Inventor
约翰·克兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avic Mountain LLC
Original Assignee
Avic Mountain LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avic Mountain LLC filed Critical Avic Mountain LLC
Publication of CN107613973A publication Critical patent/CN107613973A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201680016569.4A 2015-03-18 2016-03-18 化学合成吡咯连接的二价化合物的方法及其组合物 Pending CN107613973A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562134758P 2015-03-18 2015-03-18
US62/134,758 2015-03-18
PCT/US2016/023107 WO2016149608A1 (en) 2015-03-18 2016-03-18 Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof

Publications (1)

Publication Number Publication Date
CN107613973A true CN107613973A (zh) 2018-01-19

Family

ID=56919959

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680016569.4A Pending CN107613973A (zh) 2015-03-18 2016-03-18 化学合成吡咯连接的二价化合物的方法及其组合物

Country Status (8)

Country Link
US (2) US10253034B2 (cg-RX-API-DMAC7.html)
EP (1) EP3270916A4 (cg-RX-API-DMAC7.html)
JP (1) JP2018510218A (cg-RX-API-DMAC7.html)
CN (1) CN107613973A (cg-RX-API-DMAC7.html)
CA (1) CA2978097A1 (cg-RX-API-DMAC7.html)
HK (1) HK1250020A1 (cg-RX-API-DMAC7.html)
IL (1) IL254454B (cg-RX-API-DMAC7.html)
WO (1) WO2016149608A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1250020A1 (zh) * 2015-03-18 2018-11-23 Avekshan Llc 用於吡咯连接的二价化合物的化学合成的方法及其组合物
US10703762B2 (en) 2015-08-28 2020-07-07 Idemitsu Kosan Co., Ltd. Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649200A (en) * 1986-05-08 1987-03-10 Regents Of The University Of Minnesota Substituted pyrroles with opioid receptor activity
JPH03193782A (ja) * 1989-12-25 1991-08-23 Toray Ind Inc nor―BNIの製造法
DE10218582A1 (de) 2002-04-26 2003-11-06 Bayer Ag Zimtsäureamide
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US9623023B2 (en) 2012-10-22 2017-04-18 The Florida State University Research Foundation, Incorporated Class of non-stimulant treatment and ADHD and related disorders
HK1250020A1 (zh) * 2015-03-18 2018-11-23 Avekshan Llc 用於吡咯连接的二价化合物的化学合成的方法及其组合物

Also Published As

Publication number Publication date
US20180072747A1 (en) 2018-03-15
JP2018510218A (ja) 2018-04-12
EP3270916A4 (en) 2018-11-21
US10253034B2 (en) 2019-04-09
IL254454A0 (en) 2017-11-30
US20190161491A1 (en) 2019-05-30
WO2016149608A1 (en) 2016-09-22
US10654862B2 (en) 2020-05-19
EP3270916A1 (en) 2018-01-24
IL254454B (en) 2020-08-31
CA2978097A1 (en) 2016-09-22
HK1250020A1 (zh) 2018-11-23

Similar Documents

Publication Publication Date Title
WO2017069834A2 (en) Organic synthesis applications of non-aqueous fluoride salt solutions
UA128114C2 (uk) Тверді форми 3-((1r,3r)-1-(2,6-дифтор-4-((1-(3-фторпропіл)азетидин-3-іл)аміно)феніл)-3-метил-1,3,4,9-тетрагідро-2h-піридo[3,4-b]індол-2-іл)-2,2-дифторпропан-1-олу і способи одержання конденсованих трициклічних сполук, що містять заміщене фенільне або піридинільне угруповання, в тому числі способи їх застосування
IE55308B1 (en) New intermediates for the preparation of n-alkylnorscopines,process for their preparation and their use
CN104356197B (zh) 一种卡非佐米中间体及其制备方法,以及一种卡非佐米的制备方法
CN105061431B (zh) 6‑n‑(2‑(甲硫基)乙基)‑2‑((3,3,3‑三氟丙基)硫代)‑9h‑嘌呤及其制备方法和应用
CN111556863A (zh) 制备双环胍及其衍生物的方法
EP2733138B1 (en) Method for producing optically active tetrahydroquinoline
RU2762891C2 (ru) Способы получения цитотоксических производных бензодиазепина
CN112876404A (zh) 一种邻苯二甲酰亚胺型三氟甲硫化试剂的合成方法
CN109956901B (zh) 异喹啉酮类化合物的制备方法
CN103788069B (zh) 埃索美拉唑镁三水合物的制备方法
Blouin et al. Molecular Diversity of Cyclooctatetraenes through Palladium-Catalyzed Cascade Reactions
US10654862B2 (en) Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof
CN109232562A (zh) 一种7-氮杂吲哚-5-氯-6-羧酸的合成方法
CN103304467A (zh) 一步法制备n-咖啡酰色胺的方法
JPWO2015122502A1 (ja) 光学活性化合物の製造方法、及び新規な金属−ジアミン錯体
CN110272332A (zh) 一种甲氧基修饰的碳纳米环及其合成方法
CN102827080B (zh) 一种伊伐布雷定的合成方法及其中间产物
CN108314641A (zh) 一种天然产物Norpsilocin的制备方法
CN106966948A (zh) 一种偕二氟取代吡咯烷酮化合物的合成方法
CN108610340A (zh) [1,2,4]-三唑并[4,3-a]吡啶的制备方法
CN110498791A (zh) 一种亚烷基双烟碱型离子液体及其制备方法
KR101006737B1 (ko) 구리 촉매를 이용한 2-술포닐이미노인돌린 제조방법
CN107311963A (zh) 以四羰基化合物为原料合成四取代呋喃化合物的方法
CN105503705B (zh) 一种阿扎那韦相关物质及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180119

WD01 Invention patent application deemed withdrawn after publication